Fol. Biol. 2011, 57, 74-81
https://doi.org/10.14712/fb2011057020074
The Effect of ATM and ERK1/2 Inhibition on Mitoxantrone-Induced Cell Death of Leukaemic Cells
References
1. 1998) The p53 network. J. Biol. Chem. 273, 1-4.
< , M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., Stark, G. R. (https://doi.org/10.1074/jbc.273.1.1>
2. 2000) p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p3000/CBP during cell cycle and after exposure to ultraviolet irradiation. Cancer Res. 60, 896-900.
, T., Adler, V., Matusevich, E., Fuchs, S. Y., Ronai, Z. (
3. 2010) Multiple roles of ATM in monitoring and maintainig DNA integrity. FEBS Lett. 584, 3675-3681.
< , F. A., Kastan, M. B. (https://doi.org/10.1016/j.febslet.2010.05.031>
4. 2007) Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res. 67, 1046-53.
< , S. E., Rosenberg, E., Neill, S., Dent, P., Povirk, L. F., Valerie, K. (https://doi.org/10.1158/0008-5472.CAN-06-2371>
5. 1996) p53 tumor suppressor gene: from the basic research laboratory to the clinic – an abridged historical perspective. Carcinogenesis 17, 1187-1198.
< , C. C. (https://doi.org/10.1093/carcin/17.6.1187>
6. 2001) ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 11, 1052-1065.
< , K. K., Lavin, M. F., Jackson, S. P., Mulhern, T. D., (https://doi.org/10.1038/sj.cdd.4400874>
7. 2007) MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 is activated in response to inhibited Akt signaling. J. Biol. Chem. 282, 2288-2296.
< , M., Roudier, E., Högberg. J., Stenius, U. (https://doi.org/10.1074/jbc.M604953200>
8. 2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97, 10389-10394.
< , S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., Elledge, S. J. (https://doi.org/10.1073/pnas.190030497>
9. 2005) MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm. J. Biol. Chem. 280, 16651-16658.
< , M., Phillips, A., Darley, M., Blaydes, J. P. (https://doi.org/10.1074/jbc.M412334200>
10. 2005) MAP kinase pathways. J. Cell Sci. 118, 3569-3572.
< , M., Elion, E. A. (https://doi.org/10.1242/jcs.02470>
11. 2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344.
< , P. P., Blenis, J. (https://doi.org/10.1128/MMBR.68.2.320-344.2004>
12. 1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36, 10117-10124.
< , K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E., Xie, D. (https://doi.org/10.1021/bi970759w>
13. 1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
< , S. Y., Ikeda, M., Taya, Y., Prives, C. (https://doi.org/10.1016/S0092-8674(00)80416-X>
14. 2003) Gamma irradiation results in phosphorylation of p53 at serine-392 in human T-lymphocyte leukaemia cell line MOLT-4. Folia Biol. (Praha) 49, 191-196.
, S., Vávrová, J., Řezáčová, M., Vokurková, D., Pavlová, S., Smardová, J., Stulik, J. (
15. 2004) Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J. Biol. Chem. 279, 53015-53022.
< , T., Tovar, C., Yang, H., Carvajal, D., Vu, B. T., Xu, Q., Wahl, G. M., Heimbrook, D. C., Vassilev, L. T. (https://doi.org/10.1074/jbc.M410233200>
16. 2007) MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol. 39, 1467-1482.
< , F., Wahl, G. M. (https://doi.org/10.1016/j.biocel.2007.03.022>
17. 2003) Caffeine induces a second wave of apoptosis after low dose-rate γ radiation of HL-60 cells. Radiat. Environ. Biophys. 42, 193-199.
< , M., Mareková-Řezáčová, M., Vokurková, D., Szkanderová, S., Psutka, J. (https://doi.org/10.1007/s00411-003-0209-4>
18. 2007) Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. Oncogene 26, 4689-4698.
< , Y., Black, C. P., Cowan, K.H. (https://doi.org/10.1038/sj.onc.1210268>